- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01.07. | AbbVie's $2.1bn buy of Capstan lifts its immunology pipeline | ||
| 30.06. | Moderna shines spotlight on new flu vaccine data | ||
| 30.06. | INmune Bio slumps on midstage fail for Alzheimer's drug | ||
| 30.06. | Generic drugmaker Hikma pledges $1bn in US investment | ||
| 30.06. | FDA loosens restrictions on first-gen CAR-T therapies | ||
| 30.06. | Neopharmed buys Euro rights to BioCryst's HAE drug Orladeyo | ||
| 27.06. | Novo Nordisk Foundation gives $75m for R&D 'challenges' | ||
| 27.06. | Controversial project aims to make artificial human genomes | ||
| 27.06. | After FDA says no, Bayer bags EU nod for twice-yearly Eylea | ||
| 26.06. | ACIP backs block on flu vaccines with thimerosal additive | ||
| 26.06. | UK probes link between GLP-1 drugs and pancreatitis | ||
| 26.06. | First intranasal anaphylaxis drug launches in Germany | ||
| 26.06. | Vor Bio revives, thanks to $4bn+ licensing deal with RemeGen | ||
| 26.06. | Nektar eyes pivotal trials for eczema drug cast off by Lilly | ||
| 26.06. | Could a vaccine adjuvant be protective against dementia? | ||
| 26.06. | Biogen races into phase 3 with Spinraza follow-up | ||
| 25.06. | Kymera signs $750m cancer deal with Gilead as Sanofi opts in | ||
| 25.06. | FDA probing deaths with DMD gene therapy Elevidys | ||
| 25.06. | Alarm as study finds global vaccination coverage stalls | ||
| 25.06. | Sangamo cues up Fabry gene therapy filing on STAAR data | ||
| 25.06. | Germany will be first to launch PTC's phenylketonuria drug | ||
| 24.06. | Nuvalent chases after Nuvation in ROS1 lung cancer | ||
| 24.06. | AZ, Daiichi get Datroway nod in lung cancer on second try | ||
| 24.06. | ADA: Vertex closer to weaning type 1 diabetics off insulin | ||
| 24.06. | Novo Nordisk's fling with Hims & Hers ends in a bust-up |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .